CN Patent

CN110536682B — 依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合

Assigned to Genfit SA · Expires 2023-01-06 · 3y expired

What this patent protects

本发明涉及一种组合产品及其治疗用途。

USPTO Abstract

本发明涉及一种组合产品及其治疗用途。

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: CN110536682B
Jurisdiction: CN
Classification: —
Expires: 2023-01-06
Drug substance claim: No
Drug product claim: No
Assignee: Genfit SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.